Johnj Nicols News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Johnj nicols. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Johnj Nicols Today - Breaking & Trending Today

Codexis, Inc. (NASDAQ:CDXS) Short Interest Down 19.9% in June

Codexis, Inc. (NASDAQ:CDXS – Free Report) was the target of a large decrease in short interest during the month of June. As of June 15th, there was short interest totalling 3,140,000 shares, a decrease of 19.9% from the May 31st total of 3,920,000 shares. Based on an average trading volume of 908,100 shares, the days-to-cover […] ....

Johnj Nicols , Piper Sandler , York Mellon Corp , Codexis Inc , Royal Bank , Envestnet Asset Management Inc , Codexis Company Profile , Free Report , Director John , New York Mellon Corp , Asset Management , Performance Enzymes , Codexis Daily ,

Opaleye Management Inc. Has $4.46 Million Stock Holdings in Codexis, Inc. (NASDAQ:CDXS)

Opaleye Management Inc. lowered its position in Codexis, Inc. (NASDAQ:CDXS – Get Rating) by 17.1% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 957,500 shares of the biotechnology company’s stock after selling 197,500 shares during the quarter. Codexis makes up […] ....

Piper Sandler , Kevin Norrett , Johnj Nicols , Exchange Commission , Securities Exchange Commission , Tower Research Capital , Codexis Inc , Opaleye Management Inc , Opaleye Management , Get Rating , Research Capital , Global Management , Director John , Stock Down , Performance Enzymes , Codexis Daily , Nasdaq Cdxs , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Codexis (NASDAQ:CDXS) Upgraded by StockNews.com to "Hold"

StockNews.com upgraded shares of Codexis (NASDAQ:CDXS – Get Rating) from a sell rating to a hold rating in a research note issued to investors on Tuesday. Other equities research analysts also recently issued research reports about the company. HC Wainwright downgraded Codexis from a buy rating to a neutral rating in a report on Tuesday, […] ....

Kevin Norrett , Johnj Nicols , Piper Sandler , Nantahala Capital Management , Securities Exchange Commission , Codexis Company Profile , Codexis Inc , Telemark Asset Management , Blackrock Inc , Vanguard Group Inc , Investment Management , Get Rating , Stock Down , Exchange Commission , Director John , Capital Management , Asset Management , Performance Enzymes , Codexis Daily , Nasdaq Cdxs , Stocknews Com ,

Codexis (NASDAQ:CDXS) Stock Rating Lowered by StockNews.com

StockNews.com downgraded shares of Codexis (NASDAQ:CDXS – Get Rating) from a hold rating to a sell rating in a research report report published on Monday morning. CDXS has been the topic of a number of other reports. Piper Sandler lowered their price target on Codexis from $21.00 to $14.00 and set an overweight rating on […] ....

Kevin Norrett , Johnj Nicols , Piper Sandler , Envestnet Asset Management Inc , Codexis Company Profile , Codexis Inc , Acadian Asset Management , Advisor Group , Tower Research Capital , Get Rating , Trading Down , Director John , Asset Management , Research Capital , Performance Enzymes , Codexis Daily , Nasdaq Cdxs , Stocknews Com ,

Codexis (NASDAQ:CDXS) Rating Lowered to Neutral at HC Wainwright

HC Wainwright lowered shares of Codexis (NASDAQ:CDXS – Get Rating) from a buy rating to a neutral rating in a report issued on Tuesday morning, Marketbeat reports. HC Wainwright also issued estimates for Codexis’ FY2023 earnings at ($1.10) EPS, Q1 2024 earnings at ($0.27) EPS, Q2 2024 earnings at ($0.27) EPS, Q3 2024 earnings at […] ....

Johnj Nicols , Piper Sandler , Nantahala Capital Management , Codexis Inc , Investment Management , Blackrock Inc , Telemark Asset Management , Securities Exchange Commission , Vanguard Group Inc , Get Rating , Trading Down , Director John , Exchange Commission , Stephen George Dilly , Capital Management , Asset Management , Performance Enzymes , Codexis Daily , Nasdaq Cdxs , Hc Wainwright ,